Problems In Determining Her2 Status In Breast Carcinoma
Objective:Human epidermal growth factor receptor 2 (HER2) oncoprotein is overexpressed in 15-25% of breast carcinomas and associated with poor outcome. Assessment of HER2 status accurately is important to select patients who will benefit from targeted therapy.Materials and Methods:In this study immu...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2015-01-01
|
Series: | European Journal of Breast Health |
Subjects: | |
Online Access: |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/problems-n-determining-her2-status-n-breast-carcin/42210
|